05.05.2011 • NewsMichelinraw materialsraw material prices

Michelin Hikes Prices to Offset Raw Material Costs

French tire manufacturer Michelin on Wednesday said in a statement it would hike truck, earthmover and tractor tire prices in Europe to offset rising raw material costs.

Michelin said in February rising raw material costs would have a €1.5 billion ($2 billion) impact on operating income in 2011, but 75% of that was offset by price increases already announced or implemented.

Michelin said earthmover tire prices would rise up to 8% from June 1 in most European markets.

New Michelin brand truck tires would see a 7% price rise in Europe from July 1, the company said. Michelin Remix retreads would see an average of 7% price increases while other group brand tires would increase in price by 13% depending on the country.

Agricultural equipment tire prices will increase by an average of 6% for all group brands from July 1, Michelin added.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.